|1.||Zingler, Sebastian: 1 article (11/2014)|
|2.||Erber, Ralf: 1 article (11/2014)|
|3.||Lux, Christopher J: 1 article (11/2014)|
|4.||Diercke, Katja: 1 article (11/2014)|
|5.||Kohl, Annette: 1 article (11/2014)|
|6.||Wallenstein, S: 1 article (10/2000)|
|7.||Wolff, M S: 1 article (10/2000)|
|8.||Bleiweiss, I J: 1 article (10/2000)|
|9.||Weston, A: 1 article (10/2000)|
|10.||Brower, S: 1 article (10/2000)|
11/20/1999 - "These findings suggest that freshly isolated HPCB CD34+AC133+ stem cells are not susceptible to HIV-1 infection and may not be a viral reservoir. "
11/20/1999 - "Since AC133 antibody is likely to be used as an alternative to CD34 for the selection of stem cells in transplant and gene therapy situations, we examined the susceptibility of HPCB-isolated CD34+AC133+ stem cells to infection with free and cell-associated HIV-1 in vitro. "
11/20/1999 - "Freshly isolated HPCB CD34+AC133+ stem cells were not susceptible to HIV-1 infection as determined by PCR and reverse transcriptase assays. "
11/20/1999 - "Expression of CD4, CXCR4, and CCR5 receptor proteins on the progeny derived from HPCB CD34+AC133+ stem cells was detected and correlated with susceptibility to HIV-1 infection in vitro. "
|4.||Breast Neoplasms (Breast Cancer)
|1.||CCR5 Receptors (CCR5 Receptor)
|2.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|3.||Proteins (Proteins, Gene)